Naturally acquired Rift Valley fever virus neutralizing antibodies predominantly target the Gn glycoprotein
Rift Valley fever (RVF) is a viral hemorrhagic disease first discovered in Kenya in 1930. Numerous animal studies have demonstrated that protective immunity is acquired following RVF virus (RVFV) infection and that this correlates with acquisition of virus-neutralizing antibodies (nAbs) that target...
Auteurs principaux: | Wright, D, Allen, ER, Clark, MHA, Gitonga, JN, Karanja, HK, Hulswit, RJG, Taylor, I, Biswas, S, Marshall, J, Mwololo, D, Muriuki, J, Bett, B, Bowden, TA, Warimwe, GM |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
Cell Press
2020
|
Documents similaires
-
Naturally Acquired Rift Valley Fever Virus Neutralizing Antibodies Predominantly Target the Gn Glycoprotein
par: Daniel Wright, et autres
Publié: (2020-11-01) -
Rift Valley fever: biology and epidemiology
par: Wright, D, et autres
Publié: (2019) -
Electron cryo-microscopy and single-particle averaging of Rift Valley fever virus: evidence for GN-GC glycoprotein heterodimers.
par: Huiskonen, J, et autres
Publié: (2009) -
Two monoclonal antibodies against glycoprotein Gn protect mice from Rift Valley Fever challenge by cooperative effects.
par: Benjamin Gutjahr, et autres
Publié: (2020-03-01) -
Vaccine Efficacy of Self-Assembled Multimeric Protein Scaffold Particles Displaying the Glycoprotein Gn Head Domain of Rift Valley Fever Virus
par: Paul J. Wichgers Schreur, et autres
Publié: (2021-03-01)